BCL-2 Is a Therapeutic Target for Hypodiploid B-Lineage Acute Lymphoblastic Leukemia
Cancer Research - United States
doi 10.1158/0008-5472.can-18-0236
Full Text
Open PDFAbstract
Available in full text
Date
March 12, 2019
Authors
Publisher
American Association for Cancer Research (AACR)